CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $603,490 | -52.8% | 38,960 | -51.4% | 0.02% | -56.0% |
| Q1 2024 | $1,277,463 | +23.4% | 80,142 | +30.2% | 0.05% | +13.6% |
| Q4 2023 | $1,034,891 | -1.0% | 61,564 | -31.2% | 0.04% | -24.1% |
| Q3 2023 | $1,045,776 | -41.3% | 89,459 | -32.6% | 0.06% | -39.6% |
| Q2 2023 | $1,783,058 | +19.3% | 132,668 | +47.2% | 0.10% | +4.3% |
| Q1 2023 | $1,494,422 | +537.2% | 90,134 | +614.8% | 0.09% | +513.3% |
| Q4 2022 | $234,546 | +45.7% | 12,610 | +0.4% | 0.02% | +25.0% |
| Q3 2022 | $161,000 | – | 12,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |